Archive for the ‘Dangerous Drugs’ Category

Terbutaline Warning – Do Not Use for Treatment of Preterm Labor

Thursday, February 24th, 2011

Terbutaline (Brethine, Bricanyl, and Bethaire) was put on the market to prevent and treat asthma, bronchitis and emphysema.  However, some healthcare providers have used it for “off-label” treatment.

Terbutaline has been used “off-label” as a fast acting treatment for preterm labor and has been linked to numerous side effects, including birth injuries.

Common birth injuries linked to of Terbutaline, include:

  • Brain damage
  • Developmental problems
  • Birth defects
  • Autism (particularly in twin pregnancies) 
  • Speech and movement defects

Contact Cellino & Barnes with your questions.

Due to this “off-label” use and the dangers involved, the FDA is now requiring a Boxed Warning and Contraindications for this drug. The FDA has notified healthcare professionals that the injectable Terbutaline should not be used on pregnant woman for prevention of prolonged treatment of preterm labor. 

Learn more about Terbutaline

Darvon Recall – Darvocet Recall

Tuesday, November 30th, 2010

The FDA has issued a recall on Darvon and Darvocet after determining that all painkillers that contain propoxyphene create an unreasonable risk to consumers.

The FDA has also informed the generic manufacturers of propoxyphene and requested that they voluntarily remove their products as well.

Health care professionals have been asked to stop prescribing propoxyphene to their patients, and patients who are currently taking the drug are asked to contact their doctor as soon as possible to discuss switching to another pain management therapy.

Darvocet Side Effects

The following types of serious, life-threatening side effects have occurred:|

  • Heart Attack
  • Cardiac Arrest
  • Sudden Death
  • Stroke
  • Heart Failure
  • Heart Rhythm Distrurbance
  • Arrhythmia
  • Slow Heart Beat
  • Bracycardia
  • Convulsions
  • Overdose
  • Addiction

Cellino & Barnes is accepting cases where any of the above side effects have occurred.  If you or a loved one has taken Darvon, Darvocet, Balacet, Propoxyphene, or Propacet 100 and suffered from any of the above mentioned side effects, contact Ross Cellino or Steve Barnes immediately.

Our Darvocet Recall Attorneys are available to speak with you and to help determine if you may be entitled to compensation for your injuries.

FDA Drastically Restricts Access to Avandia

Thursday, September 23rd, 2010

The U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications.

These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia.

Learn more about Avandia

Visit FDA website.

Cellino & Barnes – Morphine Sulfate Recall

Thursday, April 8th, 2010

A voluntary recall was issued today for one lot of Ethex Morphine Sulfate 60 mg Extended Release tablets. The manufacturer discovered that some pills sold since April 16, 2008 may be twice as thick as they are supposed to be and contain double the morphine. This could lead to life-threatening risks of a morphine overdose.

To learn more click on Morphine Recall

Jury Awards Paxil Victim $2.5 Million

Friday, October 16th, 2009

A jury found that Paxil caused heart problems and other birth defects when used by a pregnant mother.  The maker has to pay $2.5 million for not warning about the side effect.

Read more

New York Lawyers Helping Avandia Victims

Tuesday, May 5th, 2009

 Avandia (Rosiglitazone), was created and marketed by GlaxoSmithKline, and was designed to treat people with Type 2 Diabetes in helping to control their blood-sugar level.

Although Avandia has been greatly beneficial for many people, it has also brought unwanted side effects to some.

In 2005, GlaxoSmithKline performed an Avandia study and reported preliminary results to the Food and Drug Administration (“FDA”). Then, in August 2006, they provided the FDA with a more complete version of the study, which showed a 31% higher risk of cardiovascular events, such as heart attacks, due to obstruction of blood flow.

GlaxoSmithKline was aware of the dangers posed by Avandia and various studies were made available to them as well. In May, 2007, Dr. Steven E. Nissen, a prominent cardiologist associated with the Cleveland Clinic, published a study in the New York England Journal of Medicine. Dr. Nissen’s study revealed a 43% higher risk of heart attack for those taking Avandia compared to people taking other diabetes drugs or no diabetes medication. Further, Dr. Nissen’s analysis showed a 64% elevated risk of death from cardiovascular disease.

Between August 20 and November 13, 2007, an inspection was conducted at GlaxoSmithKline. The inspection revealed a failure to report data relating to clinical experience, along with other data and information for Avandia.

Based on the representations made by GlaxoSmithKline and the information on the Avandia label, millions of people ingested Avandia believing that the drug would be safe and effective.

“As a result of GlaxoSmithKline’s representations, our clients ingested Avandia, suffered heart-related problems, such as heart attacks, and sustained physical and financial damages including pain and suffering”, stated Ross Cellino. “Cellino & Barnes has already filed many lawsuits for our Avandia victims, with more being evaluated and prepared for suit,” stated Steve Barnes.